These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29977583)

  • 1. End-Stage Kidney Disease in Patients With Autosomal Dominant Polycystic Kidney Disease: A 12-Year Study Based on the Canadian Organ Replacement Registry.
    Budhram B; Akbari A; Brown P; Biyani M; Knoll G; Zimmerman D; Edwards C; McCormick B; Bugeja A; Sood MM
    Can J Kidney Health Dis; 2018; 5():2054358118778568. PubMed ID: 29977583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010.
    Reule S; Sexton DJ; Solid CA; Chen SC; Collins AJ; Foley RN
    Am J Kidney Dis; 2014 Oct; 64(4):592-9. PubMed ID: 25134777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nocturnal Hemodialysis Compared with Conventional Dialysis for End-Stage Renal Disease Treatment in Polycystic Kidney Disease Patients.
    Xue C; Sun B; Ye X; Zhou C; Yang B; Zhang L; Yu S
    Blood Purif; 2020; 49(1-2):85-92. PubMed ID: 31722330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of autosomal dominant polycystic kidney disease patients on peritoneal dialysis: a national retrospective study based on two French registries (the French Language Peritoneal Dialysis Registry and the French Renal Epidemiology and Information Network).
    Sigogne M; Kanagaratnam L; Dupont V; Couchoud C; Verger C; Maheut H; Hazzan M; Halimi JM; Barbe C; Canivet E; Petrache A; Dramé M; Rieu P; Touré F
    Nephrol Dial Transplant; 2018 Nov; 33(11):2020-2026. PubMed ID: 29361078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unplanned 30-Day Readmission Rates for Autosomal Dominant Polycystic Kidney Disease: Insight from the Nationwide Readmissions Database.
    Saha A; Ericksen P; Liriano Cepin C; Nadkarni GN; Chan L
    Blood Purif; 2022 Nov; ():1-9. PubMed ID: 36318891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period.
    van de Luijtgaarden MW; Jager KJ; Segelmark M; Pascual J; Collart F; Hemke AC; Remón C; Metcalfe W; Miguel A; Kramar R; Aasarød K; Abu Hanna A; Krediet RT; Schön S; Ravani P; Caskey FJ; Couchoud C; Palsson R; Wanner C; Finne P; Noordzij M
    Nephrol Dial Transplant; 2016 Jan; 31(1):120-8. PubMed ID: 26311215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unilateral nephrectomy versus renal arterial embolization and technique survival in peritoneal dialysis patients with autosomal dominant polycystic kidney disease.
    Pierre M; Moreau K; Braconnier A; Kanagaratnam L; Lessore De Sainte Foy C; Sigogne M; Béchade C; Petrache A; Verger C; Frimat L; Duval-Sabatier A; Caillard S; Halin P; Touam M; Issad B; Vrtovsnik F; Petitpierre F; Lobbedez T; Touré F
    Nephrol Dial Transplant; 2020 Feb; 35(2):320-327. PubMed ID: 31747008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health Disparities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) in the United States.
    McGill RL; Saunders MR; Hayward AL; Chapman AB
    Clin J Am Soc Nephrol; 2022 Jul; 17(7):976-985. PubMed ID: 35725555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis.
    Vidal E; van Stralen KJ; Chesnaye NC; Bonthuis M; Holmberg C; Zurowska A; Trivelli A; Da Silva JEE; Herthelius M; Adams B; Bjerre A; Jankauskiene A; Miteva P; Emirova K; Bayazit AK; Mache CJ; Sánchez-Moreno A; Harambat J; Groothoff JW; Jager KJ; Schaefer F; Verrina E;
    Am J Kidney Dis; 2017 May; 69(5):617-625. PubMed ID: 27955924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival Among Incident Peritoneal Dialysis Versus Hemodialysis Patients Who Initiate With an Arteriovenous Fistula.
    Mukhopadhyay P; Woodside KJ; Schaubel DE; Repeck K; McCullough K; Shahinian VB; Pisoni RL; Saran R
    Kidney Med; 2020; 2(6):732-741.e1. PubMed ID: 33319197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular Access Type and Patient and Technique Survival in Home Hemodialysis Patients: The Canadian Organ Replacement Register.
    Perl J; Nessim SJ; Moist LM; Wald R; Na Y; Tennankore KK; Chan CT
    Am J Kidney Dis; 2016 Feb; 67(2):251-9. PubMed ID: 26386738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing AVF creation prior to dialysis start: the role of predialysis renal replacement therapy choices.
    Hanko J; Romann A; Taylor P; Copland M; Beaulieu M
    Nephrol Dial Transplant; 2012 Nov; 27(11):4205-10. PubMed ID: 22962410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is CAPD a viable option among ADPKD with end stage renal disease population in India? Its outcomes and economics.
    Kaul A; Dharshan R; Bhadhuaria D; Prasad N; Gupta A; Sharma RK
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):906-11. PubMed ID: 26354561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodialysis vascular access modifies the association between dialysis modality and survival.
    Perl J; Wald R; McFarlane P; Bargman JM; Vonesh E; Na Y; Jassal SV; Moist L
    J Am Soc Nephrol; 2011 Jun; 22(6):1113-21. PubMed ID: 21511830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal Dialysis Can Be an Option for Dominant Polycystic Kidney Disease: an Observational Study.
    Janeiro D; Portolés J; Tato AM; López-Sánchez P; Del Peso G; Rivera M; Castellano I; Fernández-Reyes MJ; Pérez-Gómez V; Ortega M; Martínez-Miguel P; Felipe C; Caparrós G; Ortiz A; Selgas R;
    Perit Dial Int; 2015; 35(5):530-6. PubMed ID: 25292408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodialysis vascular access and subsequent transplantation: a report from the ESPN/ERA-EDTA Registry.
    Boehm M; Bonthuis M; Noordzij M; Harambat J; Groothoff JW; Melgar ÁA; Buturovic J; Dusunsel R; Fila M; Jander A; Koster-Kamphuis L; Novljan G; Ortega PJ; Paglialonga F; Saravo MT; Stefanidis CJ; Aufricht C; Jager KJ; Schaefer F
    Pediatr Nephrol; 2019 Apr; 34(4):713-721. PubMed ID: 30588548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplant Dialysis and Preemptive Transplant in Living Donor Kidney Recipients.
    Lai M; Gao Y; Tavakol M; Freise C; Lee BK; Park M
    Kidney360; 2022 Jun; 3(6):1080-1088. PubMed ID: 35845334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry.
    Spithoven EM; Kramer A; Meijer E; Orskov B; Wanner C; Abad JM; Aresté N; de la Torre RA; Caskey F; Couchoud C; Finne P; Heaf J; Hoitsma A; de Meester J; Pascual J; Postorino M; Ravani P; Zurriaga O; Jager KJ; Gansevoort RT; ; ;
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4(Suppl 4):iv15-25. PubMed ID: 25165182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.